Recent and anticipated novel drug approvals (2Q 2025 through 1Q 2026)
American Journal of Health-System Pharmacy · 2025
DOI: 10.1093/ajhp/zxaf147 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Matthew H Rim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern Medicine, Chicago, IL, USA. Hauptthemen laut MEDLINE: Drug Approval, Pharmacists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Purpose
Health-system pharmacists play a crucial role in monitoring the pharmaceutical pipeline to manage formularies, allocate resources, and optimize clinical programs for new therapies. This article aims to support pharmacists by providing updates on new and anticipated novel drug approvals. Summary Selected drug approvals anticipated in the 12-month period covering the second quarter of 2025 through the first quarter of 2026 are reviewed. The analysis emphasizes drugs expected to have significant clinical and financial impact in hospitals and clinics, as selected from 58 novel drugs awaiting US Food and Drug Administration (FDA) approval. This year’s pipeline features novel therapies for rare diseases, targeted cancer treatments, and new agents for various diseases states.
Conclusion
Novel therapies continue to strengthen the current drug pipeline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Northwestern Medicine, Chicago, IL, USA.
- IPD Analytics, Aventura, FL, USA.
Zitieren
APA
Rim, M. H., Dean, C., Aliaj, E., Dandino, M., Howse, T., & Levitsky, A. M. (2025). Recent and anticipated novel drug approvals (2Q 2025 through 1Q 2026). American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf147
Vancouver
Rim MH, Dean C, Aliaj E, Dandino M, Howse T, Levitsky AM. Recent and anticipated novel drug approvals (2Q 2025 through 1Q 2026). American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxaf147
BibTeX
@article{Rim2025,
author = {Rim, Matthew H and Dean, Collin and Aliaj, Enela and Dandino, Matthew and Howse, Tyler and Levitsky, Andrew M},
title = {Recent and anticipated novel drug approvals (2Q 2025 through 1Q 2026)},
journal = {American Journal of Health-System Pharmacy},
year = {2025},
doi = {10.1093/ajhp/zxaf147}
}
EUVIMED